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ABSTRACT

Modulation of Spasticity by Trans-Spinal Direct Current Stimulation in Animals with Spinal
Cord Injury
by
Wagdy W. Mekhael, DPT

Advisor: Zaghloul Ahmed, PT, Ph.D.

Central nervous system injuries usually produce motor impairments that are
exacerbated by pathologically altered muscle tone. Abnormal muscle tone interferes with
voluntary movement and is associated with loss of dexterity. Prior work in our laboratory
demonstrated that 30-second trans-spinal direct current (DC) stimulation can temporarily modify
muscle tone in anesthetized spastic mice after spinal cord injury (SCI). These experiments
described DC-induced muscle tone responses to be polarity-dependent. That is, anodal
stimulation (current passed from the lumbar spine to sciatic nerve) decreased muscle tone, and
cathodal stimulation (current passed from the sciatic nerve to the lumbar spine) increased it. The
present study investigates the therapeutic potential of noninvasive trans-spinal DC stimulation
(tsDCS) to modulate spasticity in awake mice with SCI. The study aims to investigate the
following: 1- The effects of short-term tsDCS and repeated-sessions of tsDCS on muscle tone
and on skilled and unskilled locomotion. 2- The long-term modulatory effects of tsDCS on the
stretch reflex of the triceps surae muscle (TS), using the rate-dependent depression (RDD) of
Hoffmann’s reflex. 3- The changes in muscle tone as a result of combining tsDCS with several
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pharmacological agents, including gabapentin, morphine and MK-801. To assess spasticity in the
awake SCI mouse model, an innovative computer-controlled stretch apparatus with a mouse
holder was designed and constructed in our laboratory. The design permitted spasticity
assessment by stretching the TS at different speeds, while the animal received noninvasive
tsDCS treatment. The treatment protocol consisted of seven consecutive daily tsDCS sessions
(20 min/day), followed by spasticity evaluations for four weeks after stimulation ended. The
mice were also evaluated for two different types of locomotion: 1- unskilled locomotion using
the DigiGait treadmill system, and 2- skilled locomotion using a computer-controlled ladder
wheel, constructed in our laboratory. Results show that anodal tsDCS significantly reduced
several indices of spasticity during treatment, and for at least four weeks after simulation ended.
Additionally, anodal-tsDCS treated animals exhibited significantly improved unskilled and
skilled locomotion, and significant increase in RDD. Anodal treatment also improved the
spasticity-reducing effects of gabapentin and MK-801, and decreased morphine-induced rigidity.
In conclusion, these results show anodal tsDCS to be therapeutically effective in ameliorating
SCI-induced spasticity in mice when used alone, or in combination with gabapentin or MK-801.
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Chapter 1 – Introduction
Overview of Muscle Tone Abnormalities and Management
Hypertonia is a common muscle tone abnormality associated with spinal cord injury
(SCI). Clinically, muscle tone is determined by the amount of resistance conveyed by the muscle
during a passive stretch. A normal muscle typically possesses a healthy level of resting muscle
tone, which is usually active in the background of normal voluntary contractions. A normal level
of muscle tone is essential for coordination, preparedness to initiate movement, and maintenance
of the proper position of body joints at rest. While low muscle tone, hypotonicity, is a condition
marked by reduced resistance to a passive muscle stretch, hypertonicity is an increase in muscle
tone associated with an enhanced stretch reflex (Katz and Rymer, 1989). And spasticity is a
velocity dependent sensorymotor system disorder, recognized when increases in the stretch speed
lead to subsequent increases in muscle resistance, and vice versa (Lance, 1980). The exaggerated
tendon jerks associated with spasticity are attributed to hyperexcitability of spinal interneurons
(Elbasiouny et al., 2010), and alpha motor neurons (Mayer, 1997). Hypertonicity can vary greatly
in severity, from mild muscle stiffness to a painfully and debilitating sustained muscle contraction
(Adams and Hicks, 2005). When spasticity interferes with functional movement after SCI,
medications are usually prescribed. However, pharmacologic treatments of spasticity come with a
wide variety of side effects. For example, Botox, a well-known and widely-used spasticity drug, is
actually botulinum, an extremely potent biological toxin, which acts on the motor neurons via
inhibiting acetylcholine release. Botox administration is an invasive procedure that require
muscular injections, provides only temporary spasticity control, and has been reported to produce
adverse effects (Cote et al., 2005). Moreover, physical and surgical interventions do not provide a
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cure for spasticity (Gracies et al., 1997). Therefore, for the past few decades, a large body of
research has focused on testing safer methods to control spasticity.
Direct Current Stimulation Affects Muscle Tone
One promising approach has been the use of direct current (DC) to improve the
functional motor activities of patients with spasticity. Recent work supports the modulatory effects
of DC stimulation on CNS activity (Aguilar et al., 2011; Ahmed, 2016; Ranieri et al., 2012; Song
and Martin, 2017). The support is compelling in humans (Cogiamanian et al., 2008; Nitsche and
Paulus, 2001), and animals (Ahmed, 2014b; Bolzoni and Jankowska, 2015). For example, when
applied transcranially, anodal DC current significantly improved motor control functions in stroke
patients (Boggio et al., 2007), and reduced spasticity for at least two days after stimulation stopped
in children and adolescents with cerebral palsy (Aree-uea et al., 2014). Additionally, animal
studies demonstrated the ability of DC stimulation to induce plastic changes in CNS circuitry
(Ahmed, 2013b; Ahmed, 2014b; Song and Martin, 2017).
It has also been suggested that anodal trans-spinal DC current stimulation (tsDCS)
reduces spasticity by modulating the activity of the stretch reflex circuit (Winkler et al., 2010). The
electrophysiological mechanisms through which tsDCS influences the stretch reflex synapse have
been explained in the mid-20th century (Eccles et al., 1962). Working on cats, Eccles and his
group determined that when tsDCS passed across the spinal cord, it generated changes in the
membrane potential of the sensory afferent neurons, which in turn caused excitability changes in
their associated motor neurons. Namely, anodal tsDCS depolarized the presynaptic terminals of the
sensory afferents, decreasing their corresponding excitatory post-synaptic potential (EPSP). And
cathodal tsDCS hyperpolarized the presynaptic terminals of the sensory afferents, increasing their
EPSPs. The same findings were seen in other types of synapses: for example, in the neuromuscular
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junction of the frog, cathodal-induced hyperpolarization increased neurotransmitter release (Del
Castillo and Katz, 1954). And in the skeletal muscles of rat, cathodal DC induced
hyperpolarization of the presynaptic terminals, causing increased acetylcholine output. Anodal DC,
however, caused the opposite effect (Hubbard and Willis, 1962a). Recent animal studies have
confirmed these modulatory effects of DC stimulation. For example, intraspinal cathodal DC
stimuli, applied locally at the dorsal horn or within the hindlimb motor nuclei, reduced afferent and
motor neuron activity (Bolzoni and Jankowska, 2015). In other experiments, anodal tsDCS
reduced the amplitude of synaptically mediated responses, and cathodal current caused them to
increase (Ahmed, 2014b). Additionally, motor neurons showed decreased responses to anodal and
increased responses to cathodal tsDCS (Ahmed, 2016; Song and Martin, 2017). In humans, anodal
tsDCS was found to decrease the activity of ascending nociceptive tracts within the spinal cord,
reducing pain conduction signals (Truini et al., 2011). It also decreased the amplitude of the
cervico-medullary somatosensory potentials of the posterior tibial nerve; a reduction that continued
for 20 minutes after stimulation stopped (Cogiamanian et al., 2008). These encouraging findings
prompted this current study, which aims to test the potential noninvasive therapeutic potential of
tsDCS in treating muscle tone abnormalities in the SCI-mouse model.
Direct Current Stimulation Circuit
Two known neuronal types contribute to abnormal muscle tone and spasticity: the alpha
motor neurons (Hiersemenzel et al., 2000; Li et al., 2004) and the spinal interneurons (Kitzman,
2006; Mailis and Ashby, 1990). Ahmed, (2014a) explained a procedure designed to target the
hyperactivity of both types of neurons, utilizing two different loops in one DC circuit setup (figure
1-1a). First, by targeting the DC flow between the spinal cord (a1 branch) and the sciatic nerve (c2
branch), the excitability of both spinal motor neurons, and afferent neurons was modulated.
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Second, by targeting the DC flow between the spinal cord (a1) and the abdominal skin (c1), the
excitability of the interneurons in the spinal cord was also influenced. The author also explained
that the a2-c2 loop was designed to provide a charge balance, and deliver relatively higher DC
values to the spinal cord, and only sub-threshold DC values to the sciatic nerve. This loop was
crucial to avoid the deleterious effects of monopolar stimulation. However, this circuit was
designed for anesthetized mice to receive DC immediately post-SCI, through electrodes placed
invasively (surgically) under the skin. This current study proposes a new noninvasive method of
DC delivery in awake mice, utilizing over-skin electrodes. Prior studies that tested the effects of
tsDCS on neuronal circuits in mice utilized anesthetized animals. And while these studies provided
great deal of information about the effects of DC, trials on anesthetized animals carry less clinical
potential. Therefore, in this current study, we utilize awake mice to eliminate the side effects of
anesthesia and bring tsDCS closer to clinical application.
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Figure 1-1
a

b
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Figure 1-1

DC stimulation circuits

a, trans-spinal DC stimulation circuit was previously developed in our laboratory to modulate
muscle tone in anesthetized mice using trans-spinal DC stimulation (Ahmed, 2014a; Ahmed,
2016). The circuit permits DC current to pass un-attenuated to the spinal cord, and attenuated to
the sciatic nerve. b, a modified rendition of the original circuit in (a), used with over-skin
noninvasive tsDCS in awake animals, as a permanent component of the mouse holder (figure 2-2).
This was accomplished by keeping the anode (a) conductor intact, and dividing the cathode into
two branches: one branch (c1), connected directly to the abdominal electrode, second branch (c2),
connected to the sciatic nerve electrode. DC in the c2 branch was attenuated by passing through a
300 KΩ resistor to produce 0.3 mA at the sciatic nerve.
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Hypothesis and Aims
This study hypothesizes that noninvasive tsDCS (delivered through over-skin
electrodes) can be used to reduce abnormal muscle tone and stretch responses (spasticity) tested in
the triceps surae muscle (TS), and will improve recovery of locomotion and skilled movement in
mice after SCI. The aims of this study are as follows: 1- To test the immediate and short-term
effects (60 minutes) of anodal and cathodal tsDCS on muscle tone, in awake mice with spasticity,
following SCI. 2- To compare the effects of invasive (implanted electrodes) and noninvasive
(over-skin) tsDCS on muscle tone in mice with spasticity, following SCI. 3- To test the long-term
effects of repeated, longer-duration anodal and cathodal tsDCS on muscle tone in awake mice with
spasticity, following SCI. For the latter aim, the mice will receive daily, 20-minute, sessions of
tsDCS for 7 days, and will be followed for 30 days. 4- To test the modulatory effects of longerduration, anodal and cathodal tsDCS on the stretch reflex circuit (using the rate-dependent
depression (RDD) of the Hoffman reflex) in lightly anesthetized mice with spasticity, following
SCI. 5- To test long-term effects of repeated-sessions anodal and cathodal tsDCS on spasticity and
recovery of skilled locomotion in animals with SCI. 6- To test the immediate and short-term
effects of tsDCS on muscle tone after the injection of the following drugs: Neurontin (gabapentin),
morphine, and Dizocilpine (MK-801).
Considering the strong evidence obtained from the preliminary experiments on
anesthetized mice in our laboratory (Ahmed, 2014a; Ahmed, 2014b), it can be expected that the
tsDCS modulatory effects on spinal cord activity can have a long-term effect, and maybe used to
control muscle tone abnormalities in the SCI mouse model. Controlling muscle tone abnormalities
is expected to improve motor function of mice presenting with neurological impairments after SCI.
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These experiments will also help investigate the possible interactions and combined effects of
tsDCS with some drugs that are known to have an impact on muscle tone.
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Chapter 2 – Methods and Material
Animals
Adult female CD-1 mice (n = 90, weight 27-37 g) were used for all experiments (table
2-1). In this study, “sham” refers to mice that had received SCI, went through the protocol steps of
the experiment, but did not receive tsDCS treatment. “Control” or “healthy” refers to mice that did
not receive SCI, went through the protocol steps of the experiment, and did not receive tsDCS.
In the pharmacologic studies, “experimental” refers to animals that received the drug
being tested with tsDCS, while “control” refers to mice that received the drug, but no tsDCS.
“Anodal group” identifies mice that received anodal tsDCS. In this group, the anodal
electrode was positioned over the SCI site, and the current passed from the spinal cord to the
sciatic nerve. “Cathodal group” identifies mice that received cathodal tsDCS. In this group, the
cathodal electrode was positioned over the SCI site, and current passed from the sciatic nerve to
the spinal cord. Both the anodal and cathodal groups are called the treatment groups. All study
protocols were approved by the College of Staten Island’s Institutional Animal Care and Use
Committee.
For each stretch parameter tested using the apparatus, two sets of data were collected: a
set collected while the animal was awake, and another set collected while the animal was under
full isoflurane anesthesia. The data collected while the animal was anesthetized represented the
passive resistive forces of muscle and connective tissue. To isolate the neuronal component of the
stretch resistance from that caused by passive tissue, the value of the tested parameter collected
during anesthesia was deducted from that collected while the animal was awake. This method
ensured that only the neuronal contribution of the stretch response will be analyzed.
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Charles River Laboratories (USA) supplied the Breeder CD-1 mice. The College of
Staten Island vivarium conducted the pairing and breeding process. All animals were placed in
polycarbonate ‘Shoebox’ cages, and housed in a standard facility, where they were kept at 12 h
light/dark cycle, and room temperature set to 70 °F and humidity averaged 30-70%. Each cage
measured 7.25″ W × 11.5″ D × 5″. The animals were housed 3-5 per cage before the beginning of
the study, then individually immediately after they received the spinal cord injuries. No
environmental enrichments, such running wheels or toys were supplied in the cages. Cage
maintenance included cleaning twice a week, and daily checks for food, water and wellness. Cage
bedding was supplied by Andersons Bed-o’Cobs (USA). Mice had ad libitum access to filtered
water and food during the entire length of the experiment, Purina Mouse Chow #5015 (LabDiet,
USA).
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Study Type

Number of Animals

Long-term effect of tsDCS

49

Immediate effect of tsDCS

16

Effect of tsDCS using implanted electrodes

4

Morphine and effect of tsDCS

6

MK-801 and effect of tsDCS

8

Gabapentin and effect of tsDCS

7

Table 2-1

The number of animals assigned to each experiment

A total of 90, female, CD-1 mice were used in all experiments.
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Spinal Cord Contusion Injury
A ketamine/xylazine cocktail (90/10 mg/kg, i.p.) was used to deeply anaesthetize the mice.
A laminectomy at thoracic (T) 10 vertebra was conducted to expose T13 spinal segment. The IH
Spinal Cord Impactor (Precision Systems & Instrumentation, IH-0400; VA, USA) was used to
standardize the contusion SCI force for all mice. The impactor was fully computerized once the
desired contusion force level was selected using the system’s software. Impact force level was
selected at 60 kdyn. This impact force level was determined based on data collected from a
preliminary SCI contusion study using the impactor. The aim of the preliminary study was to
determine the most ideal SCI contusion force needed to produce spastic mice. This was
accomplished by creating contusion injuries in mice utilizing progressive impact forces. Mice
impacted at 60 kdyn produced ideal spastic behavior, approximately 2-3 weeks post-injury (the
number of animals used in the preliminary study is not included in table 2-1). All contusion
impacts were conducted using the standard mouse tip (diameter = 1.3mm) at T13 spinal cord level,
which was exposed by the laminectomy. Overlying muscles and skin were sutured after the
contusion procedure. Next, the surgical site was covered with a layer of gentamicin sulfate
ointment to prevent infection. The mouse then received a number and was placed on a warm pad
(30 °C) for recovery.
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Stretch Apparatus
A computer controlled stretch device was assembled from a stepper motor (ARCUS
Technology INC, DMX-UMD-23, CA USA), a foot presser mounted on a force-displacement
transducer (GRASS Technologies/NATUS, FT03, CA USA) connected to a bridge amplifier (Kent
Scientific Corporation, Torrington, CT) (figure 2-1a, left), and a mouse holder (figure 2-2). The
foot presser (figure 2-1a, right) was manufactured in our laboratory using 4.5 cm, number 8
threaded rod, screwed at one end into a rigid 0.5x1.5 poly (vinyl chloride) (PVC) pad. The PVC
pad was then heat-molded into a U-shaped plate to accommodate the flat surface of a mouse’s hind
foot. The other end of the rod was screwed into the receiving inlet of the force-displacement
transducer. The transducer was permanently fixed to a linear rail-guided carriage (ZNT Automatic
Technology Co, SGB15NUU; Zhejiang, China). The rotational movement of the stepper motor is
converted into linear displacement at the carriage using a set of jointed flat-aluminum rods.
Two computer software programs were utilized to control the stepper motor and
perform the online (during) stretch and electromyogram (EMG) recordings: The first, a stepper
motor control software (ARCUS Technology INC, DMX-UMD GUI, CA USA) was re-written to
permit the execution of three consecutive timed stretches, separated by two 10-second recovery
intervals. The stepper motor was programed to provide three different stretch speeds: 18,180, and
1800˚/s, which correspond to 3, 30, and 300 RPM, respectively. The second, LabChart-7 bundled
with PowerLab data acquisition system software (ADInstruments, Colorado Springs, CO) was
used for gathering and analyzing of the data.
The following stretch parameters were collected: Active resistance peak amplitude,
active slope, EMG area, and EMG amplitude. Active peak resistance is calculated as the height of
the resistance trace relative to baseline (before the stretch). Active slope is calculated as the first
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derivative of the rising phase of the muscle resistance in response to stretching. EMG amplitude is
calculated as the height of the EMG trace relative to baseline. EMG area is calculated as the area
covered by EMG activity traces, as calculated by the LabChart software.
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Figure 2-1
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Figure 2-1

Set up and procedure for testing spasticity in mice

a, the stretch apparatus, constructed from stepper motor, movement arm, force-displacement
transducer, and mouse holder. The system was controlled by computer software. Right image
shows the positioned hindlimb mounted on the mouse holder, being tested for spasticity. b, Top:
examples of muscle resistance traces recorded at three speeds: Speed 1 = 18 °/s; Speed 2 = 180 °/s;
Speed 3 = 1800 °/s; the bottom two traces show raw (blue) and root squared (green) EMG. Left
recordings are taken during awake condition, and right recordings are taken while the animal was
fully anesthetized with isoflurane. * denotes EMG traces presence during deep anesthesia. c, Left:
graph depicts the measured rising slope and peak force. Right: overlaid traces recorded during
speed 1 showing the effect of isoflurane.
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Mouse Holder
The mouse restraining system, fabricated in our laboratory (figure 2-2), is made of three
components: 1- A clear Plexiglas acrylic tube that served as the mouse holding chamber. 2- An
internal adjustable support system made of a clear acrylic concave stabilization plate. The location
of the plate could be adjusted along the length of the chamber linearly via a handle that protruded
through a cutout made into the entire length of the tube. The concave surface of the plate was
designed to contour to the back of the animal, securing it dorsally, and could be adjusted externally
to different mouse sizes. 3- Four over-skin stimulating electrodes. Each electrode was made of
wick-covered 1x1.5 cm stainless-steel plate. One of the electrodes was permanently fixed to the
floor of the holding chamber, serving as the abdominal conductor. The second electrode was
permanently fixed to the middle of the stabilization plate, serving as the dorsal conductor. This
electrode could be aligned with the desired stimulation site on the spinal cord by moving the
handle. The remaining two electrodes could be adjusted linearly by sliding into cutouts on the long
sides of the stabilization plate, serving as the left and right sciatic nerve conductors. The design of
the sciatic nerve electrodes enabled the positioning of the electrode directly over the sciatic nerve
location on the skin. All electrodes had external connectors through the acrylic surface of the
mouse holder to the current source. Clear acrylic was chosen to permit continuous visualization of
the animal, and ease of cleaning. The abdominal surface of the holding chamber contained two
openings, one for each of the animal’s hindlimbs. Each opening equipped with knee stabilizer pad
to ensure full knee extension during testing. A third smaller opening on the abdominal surface of
the holding chamber served as an injection access point for intraperitoneal (i.p.) drug
administration. Before testing, a cap with an opening in the center was placed on the anterior end
of the holding chamber for breathing and isoflurane administration.
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The detachable holding chamber was mounted on a support system made of an acrylic
base and stand. The stand ended in an acrylic tubular clamp on which the holding chamber was
inserted. The tubular clamp permitted rotational adjustment of the animals paw under the foot
presser, and the selection of either hindlimb to be tested. To limit the hindlimb movement to the
ankle joint during stretching; another acrylic stand was created to secure the distal leg. The stand
ended in an adjustable stainless steel ankle stabilizer clamp that could be moved in the x, y and z
axes. This was necessary for proper alignment of the foot under the presser, and adjusting the hip
angle of the animal before stretching.
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Figure 2-2
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Figure 2-2

Assembled mouse holder

Designed to permit concurrent stretch and EMG testing during tsDCS, the mouse holder consists
of a chamber, internal adjustable support system, and stimulating electrodes. Mounted on an
acrylic stand, the holder contains four internal over-skin electrodes with external connectors to a
power source: one abdominal (not shown), one spinal, and two sciatic nerve electrodes. Left sciatic
nerve electrode is not shown.
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Direct Current Stimulation Circuit and Electrodes
Circuit and power source
The tsDCS protocols of this study required the modification of a trans-spinal circuit that
was originally designed in our laboratory to be used with anesthetized animals (Ahmed, 2014a).
The original circuit was modified to pass DC to the spinal cord, and the sciatic nerve of the most
affected limb, noninvasively, using over-skin electrodes. To prevent damage to the sciatic nerve,
the current passing into the sciatic nerve electrode was attenuated. As shown in figure 1-1b, this
was accomplished by keeping the anode (a) conductor intact, and dividing the cathode into two
branches: the first branch (c1), connected directly to the abdominal electrode, carried un-attenuated
current. The second branch (c2) was passed through a 300 KΩ resistor to attenuate current to the
sciatic nerve. The same circuit was used for the two different protocols of tsDCS utilized in our
experiments: Over-skin, and Implanted-electrodes. As a current supplier, a GRASS stimulator with
a dedicated DC unit was used (GRASS Technologies/NATUS, S88, CA USA) (Ahmed, 2016). By
switching the polarity of the current source, the circuit design permitted instant reversal of the
current direction from anodal to cathodal, and vice versa. The circuit design was effective in
attenuating sciatic nerve current: For each 1.5 mA passing through the spinal-abdominal
electrodes, there was only 300 μA passing through the sciatic nerve circuit. Monitoring of current
parameters and the verification of DC attenuation was performed in the beginning, during, and at
the end of each experiment using a bench-top digital multi-meter (Agilent/Keysight Technologies,
34401A, CA, USA).
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Electrodes
Over-skin mouse-holder electrodes
Four mouse-holder electrodes designed for over-skin tsDCS were fabricated to permit
concurrent over-skin tsDCS while testing the animal by the stretch apparatus (figure 2-1). The first
electrode was permanently fixed to the middle of the stabilization plate, serving as the dorsal
conductor, and connected to the anode (a). The second electrode was permanently fixed to the
floor of the holding chamber, serving as the abdominal conductor, and connected to the (c1)
branch. The remaining two were the sciatic nerve stimulating electrodes. Depending on which
sciatic nerve was being stimulated, the corresponding electrode would be connected to the (c2)
branch. To protect the sciatic nerve, current passing into the c2 branch was attenuated using a split
current circuit (figure 1-1b). Each electrode was made of wick-covered 1x1.5 cm stainless-steel
plate.
Implantable electrodes system
To provide under-skin trans-spinal DCS in awake animals, an implantable electrode
system was fabricated according to (Ahmed, 2016). The system is made of spinal, abdominal and
cuff electrodes.
Spinal and abdominal electrodes
Each electrode was fabricated using a stainless-steel plate (1.5 mm wide, 3 mm long, 50
μm thick), placed in between soft cotton‐wick fabric (0.5 mm thick) and silicone rubber (178 μm
thick) (Ahmed, 2016). Silicone adhesive was used to fuse all three layers. The electrode was, then,
left to dry in room temperature overnight. Both spinal and abdominal electrodes were identical and
differ only in implant location. The ready to use electrode (10 mm wide and 15 mm long) was
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soaked in sterile 0.9% saline solution for 3 hours before implanted. The spinal electrode was
placed over the spinal column between T13‐L6 vertebrae. The abdominal electrode was placed
between the skin and the abdominal wall.
Cuff electrode
The cuff electrode was fabricated according to Ahmed, 2016. A class of silicone tubing
suitable for surgical implanting was used (2‐mm outer diameter (OD), 3 mm long, 1.5‐mm inner
diameter (ID); AlliedSil) (figure 2-3). The conductors were made of stainless-steel wire (280‐μm
overall diameter, 10 strands, 45‐Ω/foot impedance, nylon insulation material; Cooner Wire)
(Ahmed, 2016). This wire was chosen due to the high degree of flexibility needed for implantation.
In order to pass the wires into the silicone tubing, the hub of a 27‐gauge needle was snipped and its
shaft was passed through the silicone tubing. Then the stainless-steel wires were passed through
shaft’s lumen (Ahmed, 2016; Akay, 2014). A soldering iron was used to melt and remove the
insulation from the portion of the wire that would act as the conductor within the silicone tube. The
ends of the wires were then tied to prevent slipping from the silicone tubing. The distance between
the two sciatic nerve conductors within the cuff was fixed at 2 mm for all electrodes. A (6 cm),
number 6–0, silk suture was tethered between the two wires through the silicone tube to secure it
during implanting. To prevent electrical current conduction in the tissue that surrounds the cuff,
the silicone tubing, wire knots, and suture, were covered with silicone adhesive. To prevent
tangling of the remaining wires during animal movement, they were clamped using a thinner
silicone tubing (51‐μm inner diameter, 5‐mm long) (Ahmed, 2016). Silicone adhesive was then
used to fill the thin tube. Next, a cut was made along one side of the 4mm length of the silicone
tubing to allow the cuffing of the sciatic nerve by the electrode. Using a fine-tipped solder, the
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loose end of each wire was then connected to a mini connector. The connectors from the nerve
cuff, the spinal and abdominal electrodes were bonded together using super glue.
Implanting the cuff electrode system
The electrode system was then sterilized with 100% alcohol in preparation for
implantation. To induce deep anesthesia, the animals were injected with a ketamine-xylazine
cocktail (90% ketamine/10% xylazine, mg/kg, i.p). Deep anesthesia was verified when the animal
stopped exhibiting withdrawal reflex response to hind foot stimulations, using forceps (Ahmed,
2016). They were then shaved on the thoracic back, and the most visually spastic hindlimb. Next,
the area was disinfected with betadine before surgery started. Two incisions were made to the skin
of the thoracic back, and the skin of the most spastic hindlimb, overlaying the sciatic nerve. To
implant the electrode system, the spinal electrode was sutured with the silicone rubber side up, and
the fabric side down, in complete contact with the spinal cord, covering vertebral levels between
T13 to L6. The abdominal electrode was laid with the silicone side against the lateral abdominal
wall and the fabric side pointing towards the deep side of the skin.
To attach the cuff electrode around the sciatic nerve, the sciatic nerve had to be
exposed. This was done by dissecting the fascia between two muscles, the gluteus superficialis and
biceps femoris. Once the muscles were separated, the sciatic nerve was freed from the surrounding
connective tissue, and meticulously placed within the cuff (Ahmed, 2016). The cuff was, then,
anchored to the gluteus superficialis muscle with one suture. To enhance the conductivity of the
electrodes, sterile saline was used to moisten the tsDCS electrodes and completely fill the silicone
tubing of the cuff. The surgical site was, then, covered with a layer of gentamicin sulfate ointment
to prevent infection. The mouse then received a number and was placed on a heated tray (30 °C)
for recovery.
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Figure 2-3
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Figure 2-3

Implantable electrode system

a, the cuff electrode. b, left, the assembled implantable electrode system. Right, the animal moved
freely after the electrode system was implanted with no abnormalities (with permission from Dr.
Zaghloul Ahmed)
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The Effects of Direct Current Stimulation on Spasticity in Combination with
Pharmacological Agents
Drug administration and protocols
Each animal was weighed then mounted to the stretch apparatus, and a baseline
recording was taken before drug administration. Drug dose was calculated based on body weight.
All control animals of the drug studies received sham tsDCS by going through the exact process as
the experimental animals without turning the current on.
Isoflurane
In order to separate the passive and neuronal components of stretch resistance, a set of
data were collected while the animals were fully anesthetized. Isoflurane was chosen as the drug of
choice for this step due to its fast elimination half-time. Isoflurane was administered to all animals
at the end of each study via inhalation: A Q-tip was soaked in isoflurane until saturated, then
brought in contact with the animal’s nose through an opening in the cap of the mouse holding
chamber.
Morphine
Morphine was dissolved in a sterile 0.9% saline solution, and administered in 30
mg/kg, i.p. Two groups of uninjured mice were used for this study: 1) an experimental group
(n=5), received anodal tsDCS, 2) a non-stimulated, control group (n=2). All animals were tested
using the stretch apparatus for stretch resistance and corresponding EMG activity. The study
protocol proceeded as follows: a baseline recording was taken, followed by morphine injection.
Then another recording was taken 35 minutes after injection to test morphine effect before tsDCS.
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Subsequently, to test responses to morphine rigidity during tsDCS, more recordings were taken
immediately, 10 minutes, and 20 minutes after anodal tsDCS treatment started.
Gabapentin
Gabapentin (GABAp) was dissolved in a sterile 0.9% saline solution, and administered
in 50 mg/kg, i.p. Two groups of mice with SCI were used for this study: 1) an experimental group
(n=6) received anodal tsDCS, 2) a non-stimulated, control group (n=2). All animals were tested
using the stretch apparatus for stretch resistance and corresponding EMG activity. Initially, a
baseline recording was taken before GABAp injection. Then another recording was taken 30
minutes after injection to test GABAp effect before tsDCS. Subsequently, to test responses to
spasticity during tsDCS, more recordings were taken as follows: during anodal tsDCS, when the
anodal current was turned off, during cathodal tsDCS, and when the cathodal current was turned
off. Similarly, the same animal group was used to test the effect of a longer duration (20 minute) of
anodal tsDCS treatment after GABAp injection.
MK-801
MK-801 was dissolved in a sterile 0.9% saline solution, and administered in 0.6 mg/kg,
i.p. Two groups of mice with SCI were used for this study: 1) an experimental group (n=6),
received anodal tsDCS, 2) a non-stimulated, control group (n=2). All animals were tested using the
stretch apparatus for stretch resistance and corresponding EMG activity. Initially, a baseline
recording was taken before MK-801injection. Then another recording was taken 55 minutes after
injection to test MK-801effect before tsDCS. Subsequently, to test responses to spasticity during
tsDCS, more recordings were taken as follows: during anodal tsDCS, when the anodal current was
turned off, during cathodal tsDCS, and when the cathodal current was turned off.
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During and Short-Term Effects of Direct Current Stimulation
To examine changes in spasticity in response to the immediate (during) and shortduration tsDCS, SCI-female CD-1 mice were randomly selected to one of three groups: anodal
(n=5), cathodal (n=5), or sham (n=6). The animals of the anodal and cathodal groups received one
tsDCS treatment according to their group assignment for 20 minutes, at 1.5 mA. Animals of the
sham group went through the same procedure as the other two groups, but received no tsDCS.
Prior to testing and tsDCS, the skin areas covering the SCI injury site and the sciatic nerve of the
most affected hindlimb were shaved. The shaved skin of the animal and the mouse holder
electrodes were wetted with 3% NaCl solution to promote DC conduction. Then the animal was
placed in the mouse holder, mounted on the stretch apparatus, and received a baseline recording
before tsDCS started. Once a baseline recording was taken, the tsDCS, whether cathodal or anodal,
was turned on and went uninterrupted for the entire treatment period of 20 minutes. More
recordings were taken while the animal was receiving tsDCS (during), immediately after the
current was terminated, and every 10 minutes for 60 minutes.
Procedure of Repeated-Session (Long-Term) Direct Current Stimulation
This study was conducted to investigate the long-term effects of repeated-sessions
anodal and cathodal tsDCS on spasticity in animals with SCI. Female CD-1 mice with SCI were
randomly selected to one of three treatment groups: anodal (n=16), cathodal (n=15), or sham
(n=10). A fourth group (n=8), did not receive SCI, served as the non-injured control (healthy
group). All animals received initial baseline testing, which included the following: peak resistances
at 3 different stretch speeds, EMG activity, skilled locomotion testing, and locomotion recovery
testing. A total of nine mouse holders were fabricated to provide tsDCS to multiple animals,
simultaneously. All animals were shaved in the same manner discussed above in the short-term
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study. One shave on the first day of the long-term study was sufficient for the entire week of
tsDCS sessions. The shaved skin of the animal and the mouse holder electrodes were wetted with
3% NaCl before each session. Animals of the anodal and cathodal groups received daily 20-minute
tsDCS (1.5 mA) treatments for 7 days, according to their group assignment. Animals of the sham
and control groups went through the same procedure as the treatment groups, but received no
tsDCS intervention. Using the same baseline testing parameters, the animals were reevaluated
immediately after the conclusion of the 7-day tsDCS treatment period, then at two weeks, and four
weeks post-treatment. Additionally, following the last evaluation, the animals were tested for ratedependent depression of the Hoffman reflex.
Locomotion Recovery Testing
The DigiGait system (Mouse Specifics Inc., Framingham, MA) was used to quantify
locomotor recovery following SCI and tsDCS treatment (figure 3-4a). The system films the ventral
aspect of the animals through a transparent treadmill belt. The system includes software that
employs algorithms to quantify the characteristics of animal locomotion. All groups were tested
four times by the DigiGait system: before, immediately after, two, and three weeks after tsDCS
interventions. The control group was tested twice, two weeks apart. During testing, a minimum of
20 steps were collected at two speeds: 10 cm/s, and 20 cm/s. Three parameters measured during the
stance phase of the mouse locomotion were chosen. These parameters are sensitive to changes in
locomotion as a response to changes in muscle tone after tsDCS. These parameters are as follows:
the peak paw area, rising slope and falling slope. Peak paw area is calculated as the maximum
contact area of the foot of the mouse with the DigiGait treadmill belt. This rising slope is an
indicator of the speed of locomotion during the first half of the stance phase of the mouse
locomotion cycle. The stance phase is the segment of the locomotion cycle when the foot of the
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mouse is in contact with the treadmill belt. The falling slope is an indicator of the speed of
locomotion during the second half of the stance phase of the mouse locomotion cycle.
Skilled-Locomotion Recovery Testing
The ladder-wheel (figure 3-5a) was assembled in our laboratory from a stepper motor, a
driver, and a controller (ARCUS Technology INC, DMX-UMD-23, CA, USA). The speed and
direction of the wheel is controlled by custom-written software. The wheel is made from Plexiglas
to allow side visualization. Spaces between rungs were variable to prevent memorization. A
camera was placed under the animal to record foot faults. Animals were tested before stimulation
started and once a week for three weeks after stimulation ended.
Video analysis of the ladder-wheel task
For each recorded session, a continuous 90 second video underwent a frame-by-frame
analysis using a foot fault scoring system previously described by Metz and Whishaw (2009) (see,
table 2-2). The score for each of the animal’s hindlimbs was calculated by multiplying the number
of foot fault by its corresponding score for each criterion according to table 2-2 to get the
criterion’s score. Then the scores for all criteria are added to find the total score for each of the
hindlimbs.
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Foot Fault

Score

Description

Total miss

0

Assigned when a limb completely misses a rung and a fall occurs. A fall
is defined as a limb deeply falling in-between rungs with body posture
and balance disturbed.

Deep slip

1

Assigned when a limb is initially placed on a rung, then it slips off upon
weight bearing and this causes a fall.

Slight slip

2

The limb is placed on a rung and then slips off upon weight bearing.
However, the slip does not result in a fall and the animal is able to
maintain balance and a coordinated gait.

Replacement

3

The limb is placed on another rung in the same step (score 3) and then
slips and falls in-between rungs (score 1). For this a score of 1 is
recorded. When a fall occurs, only the limb initiating the error is rated
placed on a rung, but before it is weight bearing it is quickly lifted and
placed on another rung.

Correction

4

When a limb aims for one rung yet is placed on another rung without
touching the original rung. Alternatively, if a limb is placed on a rung
and is quickly repositioned while remaining on the same rung.

Partial

5

placement

forelimb, or with the heel or toes of the hindlimb.

Correct

6

placement

Table 2-2

The limb is placed on a rung with either the wrist or digits of the

The mid-portion of the palm of a limb is placed on a rung and can bear
the animal’s full weight.

Ladder wheel error scores

Scoring system used to evaluate skilled walking using the ladder wheel apparatus (Metz and
Whishaw, 2009).
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Rate-Dependent Depression of the Hoffman Reflex (RDD)
Following the last evaluation, animals were anesthetized using mixture of ketamine and
xylazine (90 mg/kg). The animals were shaved at the hindlimb and pelvic area. Two sets of
recording electrodes were used to record EMG, and heart rate and breathing activity. Stimulation
of the tibial nerve was achieved using concentric needle stimulating electrode (figure 3-6a, right).
Following positioning the animal on the recording station, the heart (HR) and respiratory (RR)
rates were monitored online. In deeply anesthetized animals, typically HR and RR were faster and
RR was shallower. At that level of anesthesia, the reflexes were difficult to evoke and if evoked,
the RDD was very high even in animals expressing severe spasticity. Therefore, in exploratory
experiments, the procedure was standardized by monitoring the relationship between both HR and
RR and the levels of awareness of the animal and RDD. For example, as animals awaken the HR
first becomes regular at 2 Hz then becomes more irregular between 2 and 4 Hz, and RR becomes
deeper and slower (figure 3-6b, c, and d). At the beginning of the irregular HR and deeper RR
phase, the RDD protocol was started. It consists of five trains of 5 pulses. Frequencies of the trains
were at 0.1, 0.5, 1, 2, and 5 Hz. The waiting intervals between the trains were 1-minute long.
Testing was done on both hindlimbs. Stimulation intensity was gradually increased until the
maximum H-wave relative to M-wave is seen, followed by the RDD protocol. Data was collected
using the PowerLab system (ADInstruments, Colorado Springs, CO), recorded at sample rate of 10
KHz, and filtered at low pass of 2 kHz and high pass of 100 Hz. The data were averaged using the
root square mean function with a 1-ms window using a built-in function in the LabChart software
(ADInstruments, Colorado Springs, CO). Peaks of the averaged H-wave were measured and
percent of change was calculated relative to the baseline values. RDD was calculated as the
percentage reduction = difference between the H-wave amplitude, induced by the fifth pulse and
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the first pulse in a train divided by the amplitude of the H-wave induced by the first pulse,
multiplied by 100, then multiplied by -1 to inverse the values.
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Statistical Analysis
Repeated measures ANOVA (RM ANOVA) was used to analyze the data for the
following experiments: 1- the implanted system, 2- the during and short-term effects of tsDCS on
muscle peak resistance, 3- the long-term effects of tsDCS, 4- the paw area responses to tsDCS, 5the effect of tsDCS on the rising and falling slope in locomotion, 6- effects of tsDCS on RDD, 7the effect of tsDCS on peak resistance with GABAp 7- The effect of tsDCS in MK-801-injected
mice. All assumptions for the use of repeated-measures ANOVA were fulfilled. Holm–Sidak posthoc correction was used to test differences between speeds in the stretch responses, the skilled
motion, the GABAp, the morphine and MK-801 experiments. Post-hoc analysis was used to
analyze the difference between the Anode and cathode in tsDCS treated animals. Mixed factorial
ANOVA was used to assess the difference in EMG amplitude. The two-tailed paired t-test was
used to analyze the difference between the two evaluations of the control groups in the skilled
locomotion study. Bonferroni test was used to analyze the control group evaluations. Mixed two
way repeated measures ANOVA was used to analyze the main effects between groups for the
skilled locomotion. Friedman RM ANOVA was used to analyze the tsDCS on morphine rigidity,
and Chi square to assess the difference between speeds. SPSS software was used to perform all
statistical tests (IBM Statistics, SPSS version 23). And Sigma plot software to perform the
statistics.
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Data Collection and Blindness
A total of six research assistants gathered and filed data and calculated the scores for
each animal: four research assistants transferred the stretch apparatus data from the LabChart
software to Excel sheets, and calculated the scores for each animal using embedded Excel sheets
formulas. One research assistant analyzed the DigiGait (unskilled locomotion) and ladder wheel
(skilled locomotion) videos. And another assistant ran the data into embedded excel sheet formula
to calculate animal scores. All assistants were blinded to the study hypothesis. Root mean square
(RMS) equations were embedded in LabChart with window of 0.5 ms to generate the RMS for
EMG and stretch data.
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Chapter 3 – Results
Immediate Effects of Direct Current Stimulation on Spasticity using Implanted Electrodes
To investigate the immediate changes in spasticity as a result of tsDCS in mice with
SCI, electrode systems were implanted in SCI animals (figure 2-3). After a recovery period of 48
hours, the animals were placed in the mouse holder, and mounted on the stretch apparatus for
testing. Recordings of the animal’s peak resistance and EMG were taken before and after tsDCS
(1.5 mA). Stretch testing shows that spinal anodal tsDCS treatment for 20 minutes caused
significant reduction of muscle peak resistance in all speeds (figure 3-1). The reduced peak
resistance was evident during stimulation, and continued for 60 minutes after the current stopped.
The third speed showed the most reduction of peak resistance. Contrarily, cathodal tsDCS caused
significant increase in peak muscle resistance during stimulation compared to baseline, but not
afterward. Sham treatment, on the other hand, showed no changes in muscle peak resistance in any
of the speeds. These results indicate that anodal and cathodal tsDCS have opposite effects on
spasticity: cathodal current increases stretch responses only while the current is applied, with no
significant carryover effect after the current is terminated. However, anodal current decreases
stretch responses significantly; a response that was maintained for at least a full hour after the
termination of current.
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Figure 3-1
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Figure 3-1

Implanted system to deliver anodal tsDCS

Applying anodal tsDCS (n = 4) results in significant reduction in muscle peak resistance (RM
ANOVA, for speed 1: F = 5.99, p < 0.001; for speed 2: F = 8.61, p < 0.001; for speed 3: F = 17.07,
p < 0.001). *p < 0.001 (Holm-Sidak method).
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Immediate Effects of Direct Current Stimulation on Spasticity using Over-Skin Electrodes
Unlike the mice with implanted electrode systems, these animals received tsDCS via
over-skin electrodes within the mouse holder to investigate immediate changes in spasticity as a
result of tsDCS. In corroboration with the findings from the implanted electrode study (figure 3-1),
over-skin tsDCS for 20 minutes caused significant reduction of muscle peak resistance in all
speeds (figure 3-2a). The reduced peak resistance was evident during stimulation, and continued
for the testing period of 60 minutes after the current stopped. The third speed showed the most
reduction of peak resistance. Once more, cathodal tsDCS caused significant increase in peak
muscle resistance during stimulation compared to baseline, but not afterward (figure 3-2b). Sham
treatment, on the other hand, showed no changes in muscle peak resistance in any of the speeds
(figure 3-2c). Comparable to the findings of the implanted electrodes study, these results confirm
that anodal and cathodal tsDCS have opposite effects on spasticity responses. While increases in
stretch responses following cathodal stimulation occur significantly during stimulation, they
subside after termination of current. And anodal current, again, results in a significant reduction of
stretch responses that persisted after termination of current. These findings indicate that the results
obtained from tsDCS using implanted electrodes are reproducible using surface electrodes.
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Figure 3-2
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Figure 3-2

During and short-term effects of tsDCS on muscle peak resistance in animals
with spasticity after SCI

a, anodal tsDCS (n = 6) causes reduction of muscle peak resistance in all speeds, during and for 60
min after application (RM ANOVA, for speed 1, F 3.57, p = 0.003, for speed 2, F = 3.96, p =
0.002; for speed 3, F = 13.44, p < 0.001). *p < 0.01 compared to baseline, Holm-Sidak method. b,
cathodal tsDCS (n = 5) causes significant increase in peak muscle resistance during stimulation
(During) compared to baseline (BL), but not afterward (RM ANOVA, for speed 1, F = 3.98, p =
0.002, for speed 2, F = 3.74, p = 0.002, for speed 3, F = 3.35, p = 0.005). *p < 0.05 compared to
baseline, Holm-Sidak method. c, Sham treatment (n = 5) shows no changes in muscle peak
resistance in all speeds (RM ANOVA, for speed 1, F = 1.0, p = 0.455; for speed 2, F = 0.83, p =
0.582; for speed 3, F = 1.55, p = 0.178).
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Repeated Sessions of Direct Current Stimulation Produce Long-Term Effects on
Spasticity
This study was conducted to investigate the long-term effects of repeated-sessions
tsDCS on spasticity in animals with SCI. The animals of this study were divided into 4 groups:
1- Anodal tsDCS (n = 16); received 20-minute daily anodal tsDCS for 7 days.
2- Cathodal tsDCS (n = 15); received 20-minute daily cathodal tsDCS for 7 days.
3- Sham (n = 10), SCI mice, received 20-minute daily sham tsDCS for 7 days.
4- Control (n = 8), uninjured, received 20-minute daily sham tsDCS for 7 days.
The data of four parameters were collected: Active resistance peak, active slope, EMG
area, and EMG amplitude. All four parameters were calculated by subtracting the raw amplitude
value obtained while the animal was anesthetized with isoflurane from the raw amplitude value
while the animal was awake. The differences in amplitude of active muscle resistance was assessed
using mixed factorial ANOVA using time (4 levels: pre, E1, E2, and E3), and speed (3 levels:
speeds 1, 2, and 3) as within subjects variables, and condition (three levels: anode, cathode, and
sham) as between subjects variable. There is no significant interaction between the factor of
condition and the factor of speed. The effect of different level of speed does not depend on what
level of condition is present (F (6,114) = 0.4, p = 0.81). However, there is a significant interaction
between condition and time of evaluation (F (6,114) = 2.36, p = 0.03). After adjustment for
multiple comparison (Bonferroni), there is significant marginal mean difference between anode
and cathode treated animals (p < 0.001), and between anode and sham treated animals (p < 0.001),
but no significant difference between cathode and sham treated animals (p = 0.13) in E2, E3, and
E4, but shows no significance difference between anode, cathode, and sham treated animals at E1
(p > 0.05).
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After 7 days of 20-minute daily treatment with anodal tsDCS, SCI mice showed significant longterm depression of peak muscle resistance, and significant reduction in rising slope (figure 3-3, a
and b). These significant depressions were evident in all three stretch speeds. On the other hand,
cathodal or sham treatments resulted in no significant difference. Additionally, anodal tsDCS
resulted in a significant reduction in EMG amplitude and EMG area (figure 3-3, c and d), which
was evident in all three stretch speeds. However, the cathodal or sham treatments results in no
significant difference. These results indicate that repeated stimulations using anodal current have
long-term reduction in spasticity in mice with SCI.
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Figure 3-3
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Figure 3-3

Treatment with anodal tsDCS results in long-term depression of spasticity in
mice with SCI

a, animals treated with anodal tsDCS had significant reductions in the amplitude of active muscle
resistance. The mean scores among the different levels of time within speed1 is statistically
significant compared to pre-treatment score (E1, p < 0.001; E2, p = 0.003; E3, p = 0.002, HolmSidak method). The mean scores among the different levels of time within speed 2 is statistically
significant compared to pre-treatment score (E1, p < 0.001; E2, p = 0.038; E3, p = 0.027, HolmSidak method). The mean scores among the different levels of time within speed 3 is statistically
significant compared to pre-treatment score (E1, p < 0.001; E2, p = 0.004; E3, p = 0.046, HolmSidak method). b, Anodal tsDCS results in significant reduction in rising slope. The difference in
active slope was also assessed using mixed factorial ANOVA. The analysis shows significant
interaction between time and treatments (F (2, 114) = 3.59, p = 0.03). There was no interaction
between speed and treatments. Post-hoc analysis shows significant main difference between Anode
and cathode treated animals (p = 0.015), and between anode and sham (p = 0.04) during E2, E3,
and E4. There was no difference between sham and cathode treated animals (p = 0.829). c, Anodal
tsDCS results in significant reduction in EMG area. d, Anodal tsDCS results in a significant
reduction in EMG amplitude. Both EMG area and amplitude analysis show similar results: the
difference in EMG amplitude was assessed using mixed factorial ANOVA. The analysis shows
significant interaction between time and treatments (F4, 218) = 3.63, p = 0.007). There was no
interaction between speed and treatments (F (4,218) = 0.61, p = 0.66) nor between speed, time, and
treatments (F (8,218) = 0.19, p = 0.9). Post-hoc analysis shows significant difference between
anode and cathode treated animals (p <0.001), and between anode and sham treated animals (p =
0.001). There was no difference between cathode and sham treated animals (p = 0.96).
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Locomotion Recovery
The DigiGait system was used to quantify locomotor recovery following SCI and
tsDCS treatment (figure 3-4). In general, there was significant correlation between peak area,
rising, and falling slopes in all groups (Pearson product moment correlation, p < 0.05). This
indicates that the three parameters are mechanistically and functionally linked. Anodal tsDCS
treated animals show significant increase in paw area at all evaluations during slow speed (E1-E3)
for the left hindlimb (LHL) and E1 and E2 only for the right hindlimb (RHL). Paw area is
significantly increased in E1 during fast speed for the LHL, and for the RHL. Rising slope is
significantly increased during slow speed in E1 and E2 for RHL, but not for LHL. Rising slope is
significantly increased in E1 during fast speed for RHL only. Falling slope is significantly
increased in E1 and E2 during slow speed for LHL, and for RHL. Falling slope is significantly
increased in E1 during fast speed for RHL only (figure 3-4d).
Control animals show no difference in the paw area, rising slope, or falling slope
between the two evaluations of the two limbs (figure 3-4b). However, sham treated animals show
significant decrease in evaluations (E1-E3) in paw area of the left hindlimb (LHL) during slow
speed, but not for right hindlimb (RHL). Paw area is significantly decreased in all evaluations (E1E3) during fast speed for LHL, but not significant change for RHL. Rising slope is significantly
decreased in E1 during slow speed for the LHL, but not for the RHL (figure 3-4c). Rising slope is
not changed significantly during fast speed for both hindlimbs. Falling slope is not significantly
decreased for both hindlimbs during the slow speed. Falling slope is significantly decreased in all
evaluation during fast speed for the LHL, but not for RHL.
The cathodal tsDCS treated animals show significant increase in paw area in E1 during
slow speed compared to baseline but not in E2 or E3 (figure 3-4e). No significant change is seen in
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paw area in all evaluations during fast speed. Rising slope is not changed during slow or fast
speed. Falling slope is significantly increased in E1 and E 2 for the LHL for slow speed, and for E1
only for the RHL for slow speed. There is no significant change in falling slope during fast speed.
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Figure 3-4
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Figure 3-4

Repeated treatment with anodal tsDCS results in changes in spastic animals’
locomotion patterns

a, schematic of the DigiGait system showing the general setup. Animal locomotion was tested at
two speeds: 10 cm/s, and 20 cm/s. A typical recording is shown on the top right. Three parameters
were taken for analysis: rising slope, peak paw area, and falling slope. The bottom figure shows
recordings of stance phases from a representative animal from each group. b, control healthy
animals were evaluated twice separated by 2 weeks. Gray bar for left hindlimb (LHL); blue bar for
right hindlimb (RHL); E1: evaluation 1; E2: evaluation 2. Control animals show no difference in
the paw area, rising slope, or falling slope between the two evaluations of the two limbs (p >0.05;
two-tailed paired t-test). c, sham treated animals show significant decrease in evaluations (E1-E3)
in paw area of the LHL during slow speed (RM ANOVA, F = 4.75, p = 0.009), but not for RHL.
Paw area is significantly decreased in all evaluations (E1-E3) during fast speed for LHL (RM
ANOVA, F = 5.54, p = 0.005), but not significant change for RHL. Rising slope is significantly
decreased in E1 during slow speed for the LHL (RM ANOVA, F = 3.20, p = 0.039), but not for the
RHL. Rising slope is not changed significantly during fast speed for both hindlimbs. Falling slope
is not significantly decreased for both hindlimbs during the slow speed. Falling slope is
significantly decreased in all evaluation during fast speed for the LHL (RM ANOVA, F = 4.47, p =
0.012), but not for RHL. *p < 0.05, Holm-Sidak method. d, anodal tsDCS treated animals show
significant increase in paw area at all evaluations during slow speed (E1-E3) for LHL and E1 and
E2 only for RHL (RM ANOVA, for LHL: F = 12.70, p < 0.001; for RHL: F = 17.32, p < 0.001).
Paw area is significantly increased in E1 during fast speed for the LHL (RM ANOVA, F = 7.04, p
< 0.001), and for the RHL (RM ANOVA, F = 13.32, p < 0.001). Rising slope is significantly
increased during slow speed in E1 and E2 for RHL (RM ANOVA, F = 6.06, p = 0.002), but not for
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LHL. Rising slope is significantly increased in E1 during fast speed for RHL only (RM ANOVA,
F = 4.19, p = 0.011). Falling slope is significantly increased in E1 and E2 during slow speed for
LHL (RM ANOVA, F = 10.03, p < 0.001), and for RHL (RM ANOVA, F = 13.48, p < 0.001).
Falling slope is significantly increased in E1 during fast speed for RHL only (RM ANOVA, F =
9.06, p < 0.001). *p < 0.05, Holm-Sidak method. e, cathodal tsDCS treated animals show
significant increase in paw area in E1 during slow speed compared to baseline (RM ANOVA, for
LHL: F = 7.92, p < 0.001; for RHL: F = 8.46, p < 0.001) but not in E2 or E3. No significant
change is seen in paw area in all evaluations during fast speed. Rising slope is not changed during
slow or fast speed. Falling slope is significantly increased in E1 and E 2 for the LHL (RM
ANOVA, for slow speed: F = 6.72, p < 0.001), and for E1 only for the RHL (RM ANOVA, for
slow speed: F = 3.47, p = 0.025). *p < 0.05, Holm-Sidak method. There is no significant change in
falling slope during fast speed.
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Anodal Treatment Enhances Recovery of Motor Control of Skilled Locomotion
The effect of the repeated tsDCS on skilled locomotion was investigated using a
computer controlled ladder wheel (Figure 3-5A). There was a significant difference across the four
time points in the anode treated group (F = 6.49, p = 0.002). The RHL anode treated group showed
statistically significant higher mean score in E2 compared to E1 (p = 0.001, Bonferroni). The LHL
of the anode treated group showed statistically significant higher score in E2 and E4 compared to
E1 (p < 0.01, Bonferroni) (Figure 3-5B). No other group showed significant difference across the
four time points (p > 0.05, Bonferroni).
Next, the percent change (from pre-evaluation) between groups (Figure 3-5C) was
compared. Mixed two way repeated measures ANOVA showed significant main effects among the
groups (F = 5.97, p = 0.016). Anode group showed significantly higher percent change in scores
compared to cathode group (p = 0.027, Bonferroni), and healthy group (p = 0.048, Bonferroni).
Anode group showed higher percent change than sham group, however, not statistically significant
(p > 0.05). There were no significant differences among other the groups (p > 0.05).
Overall, these findings reveal enhanced recovery of motor control of skilled locomotion in
anode-treated animals. Two major findings can be deduced from the above results: 1) since the
healthy group did not show changes in the skilled locomotion scores, this indicates no motor
learning is possible using our motorized ladder-wheel system. And that the motorized ladder-wheel
test is probing motor control and not motor learning. 2) By reducing spasticity, anodal treatment
enhances motor control.
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Figure 3-5

54

Figure 3-5

Enhancement of skilled locomotion following repeated anodal tsDCS treatment

a, left: an image of the ladder-wheel; right: consecutive frames showing a total miss occurred by
the hindlimb. b, summary plots showing mean score of skilled locomotion. Sham, SCI group that
was sham treated; healthy group, no injury/no treatment; anode, SCI group that was treated
repeatedly for 7 days; cathode, SCI group that was treated for 7 days. c, summary plots showing
percent change (of pre-treatment evaluation or first evaluation in healthy controls). Data shows as
means ± S.E. * p < 0.05 compared to pre.
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Rate-Dependent Depression of the Hoffman Reflex (RDD)
Mixed two way repeated measures ANOVA was conducted to assess the changes in
RDD. The treatment condition (independent factor, 4 levels: control, sham, anode, and cathode)
shows significant difference in the main effect among the different levels of treatment (F = 3.0, p =
0.038). There is also significant main effect of frequency (within subjects repeated factor, 5 levels:
0.1, .5, 1, 2, and 5 Hz) (F = 13.8, p < 0.001). There is not a statistically significant interaction
between frequency and treatment condition (F = 1.35, p = 0.192). The effect of different levels of
treatment does not depend on what level of frequency is present.
Multiple comparison test (Tukey) was applied to isolate which group (s) differ from the
others. As shown in figure 3-6, within control, the mean scores of RDD at frequencies 1, 2, and 5
Hz are significantly higher compared to RDD at 0.1 Hz (5 vs. 1 Hz, p <0.001; 4 vs. 1Hz, p =
0.006; 3 vs.1, p = 0.024). Within sham, the mean scores of RDD at all frequencies are not
significant compared to RDD at 0.1 Hz (p > 0.05). Within anode, the mean scores of RDD at
frequencies 2, and 5 Hz are significantly higher compared to RDD at 0.1 Hz (5 vs. 1 Hz, p <0.001;
4 vs. 1Hz, p <0.001). Within cathode, the mean scores of RDD at 1 Hz is significantly higher
compared to RDD at 0.1 Hz (p = 0.017).
Between groups comparison (Tukey) shows significant differences of RDD scores at
5Hz. RDD score at 5 Hz is significantly higher in the anode group compared to both sham and
cathode groups (p < 0.05). The control group shows significantly higher RDD at 5 Hz compared to
cathode group (p = 0.016). Overall, these findings provide physiological mechanism that
underlying the reduction of spasticity in response to repeated anode stimulation.

56

Figure 3-6
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Figure 3-6

Rate-dependent depression of Hoffman reflex after repeated sessions of tsDCS
stimulation

a, left photograph: visible attributes of spasticity in animals with SCI; right photograph showing
the recording setup. SE, stimulating electrode; RE recording electrode. The two recording traces
on the right in (a) are the raw trace (top), and the root-mean square calculated trace (bottom). b, the
respiratory rate (RR) during deep anesthesia (blue), and 45 min after anesthetic injection (orange).
c, Top: heart rate (HR) during deep anesthesia (blue), and after 45 min of injection (orange);
bottom: the full recording, with breaks, showing the HR at which RDD testing took place. d,
showing changes when RDD was tested during deep anesthesia versus during light anesthesia. e,
representative recordings from different groups. f, left: summary blots showing the average RDD
in different groups. RDD is significantly higher in control group (n = 12) for rate 1-5 Hz compared
to rate 0.1 Hz (RM ANOVA, F = 8.815, p < 0.001). RDD in sham group is significantly higher at
rates 2 and 5 compared to 0.1 Hz (RM ANOVA, F = 3.725, DF = 16, p = 0.009). RDD in anodal
tsDCS group is significantly higher at rates 1-5 Hz compared to 0.1 Hz (RM ANOVA, F = 8.598,
FD = 16, p < 0.001). RDD in cathodal tsDCS group is significantly higher at rates 1 and 5 Hz only
(RM ANOVA on Ranks, Chi-square= 16.933, n = 12, p = 0.002. *significant from RDD at 0.1Hz
in the same group (Holm-Sidak method; **significant from respective RDD in sham group (t-test).
Right: cumulative probability distribution of the groups.
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Effect of Direct Current Stimulation after Gabapentin Injection
Gabapentin (GABAp) is a drug with many pharmacologically therapeutic effects: it has
been found to treat epilepsy and reduce spasticity after SCI through multiple cellular mechanisms.
Although not a GABA receptor agonist, it has been suggested that GABAp works by increasing
GABA synthesis and inhibiting glutamatergic transmission (Kitzman et al., 2007).
This study aimed to investigate tsDCS effect on GABAp’s ability to reduce stretch peak resistance
in mice with SCI, during and after 20-minutes of anodal tsDCS. Two groups of mice with SCI
were used for this study: 1) an experimental group (n=6), received anodal tsDCS, 2) a nonstimulated, control group (n=2). Data show that there was significant decease after 30 min of
GABAp injection and further significant decrease during anodal tsDCS (figure 3-7b). In the same
group of animals, 20 min of anodal tsDCS results in further significant depression of peak muscle
resistance for speed 1, but not for the other two speeds (figure 3-7c). There was a steady reduction
of peak muscle resistance during sham treatment in the control group (figure 3-7d). The data
indicate that anodal tsDCS adds further depression to peak resistance in addition to the depression
induced by GABAp injection.
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Figure 3-7

Anodal tsDCS adds further depression to peak muscle resistance following the
depression induced by injecting GABAp

a, examples of traces of muscle force recording and their respective EMG. b, Summary plot shows
significant decrease of peak resistance after 30 min of gabapentin injection (n = 6; RM ANOVA,
for speed 1, F = 14.66, p < 0.001; for speed 2, F = 11.14, p < 0.001; for speed 3, F = 16.43, p <
0.001), and further significant decrease during anodal tsDCS (RM ANOVA, for speed 1, F =
8.96, p < 0.001; for speed 2, F = 11.68, p < 0.001; for speed 3, F = 18.20, p < 0.001). *p < 0.001
Holm-Sidak method. c, In the same group of animals, 20 min of anodal tsDCS results in
significant depression of peak muscle resistance for speed 1 but not the other two speeds (RM
ANOVA for speed 1, F = 8.63, p = 0.007). *p < 0.01 Holm-Sidak method. d, control group (n =2)
shows steady reduction of peak muscle resistance during sham treatment.
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Effects of Direct Current Stimulation after Morphine Injection
Morphine injection has long been associated with catatonic rigidity (Widdowson et al.,
1986). This study aimed to investigate whether tsDCS has an effect on morphine-induced increase
in the stretch responses in mice with SCI, during, 10, and 20 minutes after anodal tsDCS. Two
groups of mice with SCI were used for this study: 1) an experimental group (n=5), received anodal
tsDCS, 2) a non-stimulated, control group (n=2). The data show that morphine caused significant
increase in muscle resistance, 35 min after injection (figure 3-8a). And although immediate anodal
tsDCS resulted in reduction of morphine-induced muscle resistance in all three speeds, the
reduction was not significant (figure 3-8b). Additionally, there was no significance between
baseline and after 10 or 20 min of anodal tsDCS. Morphine-induced muscle resistance continued to
increase steadily during a sham treatment (no tsDCS) (figure 3-8c).
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Figure 3-8

Anodal tsDCS reduces morphine-induced muscle resistance

a, photographs showing fanning of the toes, and extension pattern of the paws. Right: strong
resistance was manually felt. Also the tail was rigid. Bottom, example of force and RMS-EMG
recorded before morphine (blue), after 35 min of morphine injection, and during the application of
anodal tsDCS (red). b, morphine caused significant increase in muscle resistance 35 min after
injection (n = 5) and this increase was reduced but is still significant by immediate application of
anodal tsDCS (Friedman RM ANOVA, for speed 1, chi square = 14.8, p = 0.005; for speed 2, chi
= 13.92, p = 0.008; for speed 3, chi square = 13.92, p = 0.008), *p < 0.05, Tukey test. There is no
significance between baseline and after 10 or 20 min of anodal tsDCS. c, morphine caused steady
increase in muscle resistance during a sham treatment (no tsDCS).
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Effects of Direct Current Stimulation after MK-801 Injection
MK-801 is an N-Methyl-D-aspartate (NMDA) receptor uncompetitive antagonist. It is
used as anticonvulsant and anesthetic (Zuo et al., 2007). This study aimed to investigate tsDCS
immediate effect on MK-801’s ability to reduce stretch resistance in mice with SCI. Two groups of
mice with SCI were used for this study: 1) an experimental group (n=6), received anodal tsDCS, 2)
a non-stimulated, control group (n=2). Data show that, compared to baseline, MK-801 caused
significant reduction in peak muscle resistance 55 min after injection. While cathodal tsDCS had
no effects on peak muscle resistance at all speeds, short term (1 min) application of anodal tsDCS
reduced peak resistance at all speeds, significantly (figure 3-9a). Control group shows stable
reduction of muscle peak resistance (figure 3-9b). These findings indicate that in SCI mice, anodal
tsDCS further depresses spasticity in the presence of MK-801.
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Figure 3-9

Anodal tsDCS further depresses Spasticity in the presence of MK801 in animals
with SCI

a, peak muscle resistance expressed as percent of baseline (n = 5,). MK801 causes significant
reduction in peak muscle resistance 55 min after injection. Furthermore, short term (1 min)
application of anodal tsDCS reduces peak resistance at all speeds. However, cathodal tsDCS has
no effects on peak muscle resistance at all speeds. The difference in the mean values among the
groups was tested using RM ANOVA, for speed 1, F = 25.5, p < 0.001; for speed 2, F = 8.3, p <
0.001; for speed 3, F = 10.5, p < 0.001). To isolate the different groups, Holm-Sidak method was
used; *p <0.001 compared to baseline; **p <0.002 compared to MK801. b, control group (n = 2)
shows stable reduction of muscle peak resistance.
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Chapter 4 – Discussion
Implantable vs. Surface Electrodes
Characterized as an upper motor neuron and muscle tone disorder, spasticity is defined
as a velocity-dependent increase in muscle resistance in response to passive stretching (Lance,
1980). Management of muscle tone pathology is a crucial component of the rehabilitation process
following SCI. This study investigated the immediate and long-term effects of tsDCS on spasticity,
and the interaction of tsDCS with certain pharmacological agents, in order to understand the
combined effects with tsDCS and possible tsDCS mechanisms of action. In this study, the
immediate effects of tsDCS were examined using two different current-delivery settings: one
utilized an implanted electrode and the other utilized a surface electrode. Initially, the electrode
systems were implanted over the spinal column and the sciatic nerve of SCI mice according to
Ahmed, 2016 (figure 2-3). And the systems were successfully used to provide anodal (spinal-tosciatic) or cathodal (sciatic-to-spinal) DCS. Anodal DCS treatment for 20 minutes using the
implanted electrode system caused significant reduction in spasticity. This reduction was
noticeable as soon as the anodal DCS started, and continued for an hour after the current stopped
(figure 3-1). Although the implantable electrode system provided precise DCS to the spinal cord
and sciatic nerve, implanting it was a tedious surgical procedure that involved possible risks of
infections and post-surgical complications. Additionally, the procedure was time consuming and
required extensive preparations before, during and after the surgery. Therefore, the effectiveness of
surface electrodes, fabricated in our laboratory, in providing tsDCS was investigated. The surface
electrodes were designed to be permanent components of the mouse holder (figure 2-1).
Additionally, provided that anodal current possessed potential modulatory effect on spasticity,
delivering the current noninvasively would hold far more clinical importance due to its non-
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invasiveness. For the experiments in this study, not only the noninvasive setup was effective in
reproducing data comparable to those obtained using the implanted system, but it eliminated the
risks and complications associated with surgery, and the time needed for preparation and recovery.
Additional important consideration in choosing over-skin electrodes over implantable electrodes is
the practicality of their use in clinical settings.
Expected Anodal Direct Current Stimulation Responses
The concurrent reduction of spasticity in response to anodal tsDCS was anticipated in
both setups of the immediate effect studies (figures 3-1 and 3-2): Eccles et al., 1962 found DC
current to be an effective modulator of synaptic activity between the motor neurons and sensory
afferents neurons within the spinal cord (Eccles et al., 1962). The anodal current on the spinal cord
caused reduction in the amplitude of EPSP in motor neurons. Additionally, Ahmed, 2014
investigated the modulatory effects of DC stimulation, and concluded that spinal-to-sciatic current
reduced the muscle and nerve responses induced by steady and transit stretches (Ahmed, 2014b).
Justification of Stretch Parameters
To quantify responses to tsDCS via the stretch apparatus, the following parameters
were used: peak muscle resistance, rising slope, EMG amplitude, and EMG area. Peak muscle
resistance (calculated in gram of muscle resistance) is a sensitive parameter, reached at the end of
the dynamic phase of the muscle stretch. The rising slope (calculated in gram/second) is a
parameter that takes into consideration the variability of the rate of change along the resistance
curve. EMG amplitude is an indicator of muscle activity; the higher the EMG amplitude, the
higher the muscle resistance. EMG area is a parameter that takes into consideration the aggregated
EMG activities in a specific period of time.
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Neuronal vs. Passive Resistive Components
Data analyzed for all parameters are the raw data (data collected while the animal is
awake) minus those collected during isoflurane anesthesia. This method of data analyses was
chosen to isolate values that represent the neuronal component of the stretch responses from
passive resistance. The data collected during isoflurane, while the animal is fully anesthetized,
represent muscle resistances that are attributed to passive forces only. The neuronal component of
stretch resistance is greatly eliminated during isoflurane application. Therefore, when isoflurane
values are deducted from the raw values, the difference will represent the neuronal component of
the stretch responses only. The elimination of the passive muscle resistance is crucial to obtaining
accurate data, since passive components can be altered due to SCI and repetitive stretching during
testing. This method also makes it possible to quantify the portion of the stretch resistance that can
be attributed to neuronal activity.
Reliability of the Stretch Apparatus
The SCI mouse model is ideal because of its availability, turnover speeds, ease of
handling, and genetic closeness to humans. To investigate the effects of tsDCS on spasticity using
this model, a tool to quantify stretch responses in mice was needed. However, there was no tool on
the market made for this purpose. Therefore, a stretch apparatus was designed to accommodate the
SCI mouse model, and then assembled in our laboratory. The sensitivity and validity of the
apparatus have been verified through a number of uses: it detected differences between stretch
responses in awake vs. isoflurane- anesthetized animals (figure 2-1). Additionally, control groups
have been tested multiple times with no or negligible differences in subsequent recordings. The
apparatus had also detected the differences between normal muscle stretch responses and those
elevated due to morphine rigidity (figure 3-8), or decreased due to the influence of GABAp (figure
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3-7), and MK-801 (figure 3-9). One feature of the apparatus proved to be of great importance to
this study is its ability to detect stretch responses at different speeds. This feature was crucial for
this study since spasticity is a velocity-dependent response.
Rate-Dependent Depression is reduced in Spastic Mice
Rate-Dependent Depression (RDD) is the attenuation of the h-reflex amplitude
following repeated-sessions stimulations (Ishikawa et al., 1966; Lloyd and Wilson, 1957; Meinck,
1976). RDD is reduced in spastic humans (Aymard et al., 2000; Nielsen et al., 1993), and animals
(Hedegaard et al., 2015; Lee et al., 2014). In our RDD study, there were no significant differences
in RDD reduction between the different frequencies in the sham group. There was significant
difference between the control and sham groups at 5 Hz (figure 3-6 F). These findings support
prior work correlating decreased RDD with increased spasticity after CNS injury (Lee et al., 2014).
Effects of Ketamine on Rate-Dependent Depression
In order to obtain RDD recordings, mice were anesthetized with a ketamine/xylazine
cocktail (90/10 mg/kg, i.p). However, RDD recordings showed dependence on the level of
ketamine anesthesia for the same animal, with increases in RDD in deeply anesthetized mice, and
decreases in RDD when the same animal was under light anesthesia. These observations indicated
that RDD was affected by ketamine concentrations in the body (figure 3-6). To eliminate the
effects of deep ketamine anesthesia, the RDD protocol was performed while the animals were
lightly anesthetized. The state of light anesthesia was accomplished when the animals reached
precise values of heart and breathing rates. These values were reached approximately 45 minutes
after anesthetic injection, where heart and breathing rates were 2 Hz and 0.5 Hz, respectively
(figure 3-6 B, C, and D). It was crucial to standardize the RDD protocol initiation point for all

71

animals. This testing setup ensured that any RDD changes were caused by the tested variables, not
the differences in ketamine levels. For future investigations, it is our recommendation to control
for the effects of ketamine when used as anesthetic during RDD protocols. The process through
which ketamine exerts its modulating effects on RDD has not been investigated. And the exact
mechanism of its anesthetic activity is not well understood (Tyler et al., 2017). However,
ketamine’s role as a nonspecific N-Methyl-D-aspartate receptor (NMDAR) antagonist has been
well supported by research (Anis et al., 1983; Sleigh et al., 2014).
MK-801
Therefore, this experiment hypothesized that NMDAR may play a role in RDD in
spastic mice. To test this hypothesis, MK-801 was used, which is an NMDAR specific antagonist,
to block ketamine activity. Our results show significant reduction in stretch amplitudes following
MK-801 injection (figure 3-9 A). These results are in agreement with prior work that explored the
role and the potential therapeutic use of MK-801 in the treatment of spasticity (Brunson et al.,
2001; Li and Tator, 1999; Simpson et al., 1995). Notably, MK-801 blocked cathodal but not
anodal stimulation effect on the stretch resistance in all three speeds. And it seems that anodal
stimulation has an additive effect that is probably mediated by a different mechanism.
Repeated Sessions of Anodal Stimulation Restore Rate-Dependent Depression in Spastic
Mice
The monosynaptic circuitry mediating the stretch reflex includes two types of neurons:
The Ia afferent sensory neurons from the muscle spindle, and the alpha motor neuron that
innervates the same muscle. The Ia afferent projects on the motor neuron to form an excitatory
synapse. In addition to stretching, the circuit can be activated with electrical stimulation to produce
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the H-reflex. The reduction of the H-reflex amplitudes associated with repeated stimulation of the
stretch reflex pathway is the result of post-activation depression (Crone and Nielsen, 1989;
Hultborn et al., 1996).
The mechanisms that underlie post-activation depression involve a decrease in the
probability of neurotransmitter quantal release from the Ia afferent due to its prior activation (Hirst
et al., 1981; Kuno, 1964a; Kuno, 1964b; Lev-Tov and Pinco, 1992). Post-activation depression is
functionally beneficial during voluntary movement, as it lowers the Ia afferent’s synaptic efficacy;
therefore, prevent clonus and oscillations (Hultborn and Nielsen, 1998) Decreased post-activation
depression; however, would increase the efficacy of the synapse, which in turn may lead to the
hyper-excitability commonly associated with spasticity (Hultborn and Nielsen, 1998).
RDD data were obtained from mice that underwent two types of stimulations, during
tsDCS and after a week of repeated tsDCS (long-term) sessions. The results show significant RDD
increases in the anode group compared to the sham group in both, the short-term tsDCS (data not
shown) and long-term tsDCS (figure 3-6). These results can be explained in light of the
modulating effects of DC current at the synaptic level. Anodal DC current, applied on the dorsum
of the spinal cord, depolarizes the presynaptic terminals of Ia afferents, decreasing motor neurons’
EPSP. However, cathodal DC current hyperpolarizes the presynaptic terminals of the Ia afferents,
increasing motor neurons’ EPSP (Eccles et al., 1962). Additionally, anodal current increases the
frequency of miniature end-plate potentials due to enhanced spontaneous release (Del Castillo and
Katz, 1954), likely causing depletion of presynaptic neurotransmitter.
In summary, the stretch reflex circuit is partially capable of modulation via embedded
mechanisms, such as the adjustment of spontaneous neurotransmitter release and post-activation
depression. These mechanisms, which are independent of higher CNS control, contribute to the
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functional decrease in the stretch reflex activity during voluntary movements. After SCI, the
mechanisms are altered and the reflex pathway becomes hyperactive (Dietz and Sinkjaer, 2007;
Little and Halar, 1985; Xu et al., 2015). However, using dorsal anodal stimulation after SCI,
normal activity within the stretch reflex pathway was restored. Worth noting, the effect of anodal
stimulation reported by Del Castillo & Katz, 1954 continued for few minutes after the stimulation
was terminated. Our repeated stimulation study results show a carryover effect that lasted for
weeks after the repeated-sessions anodal tsDCS was terminated. These findings have great
implications for future studies aiming to investigate the mechanisms of the carryover effect at the
cellular and molecular levels.
Repeated Sessions of Direct Current Stimulation Result in Long-Term Effects on Spasticity
This study was conducted to investigate the long-term effects of repeated-sessions
tsDCS (7 days of 20-minute daily treatment) on spasticity in mice with SCI. Because spasticity is
velocity-dependent, the TS was stretched at three different speeds: 18, 180, and 1800˚/s. Four data
parameters thought to be important in assessing spasticity were measured. These parameters are as
follows:
1- The peak of active resistance
2- The active slope
3- The amplitude of EMG.
4- The area of EMG
For each of these components, on the active portion was including in the data analysis.
The active component of each parameter represents the portion caused by neuronal activities,
whereas the passive component represents the portion attributed to other elements, such as
connective tissue. Each active component was calculated by subtracting the raw amplitude value
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obtained while the animal was anesthetized with isoflurane from the raw amplitude value while the
animal was awake, as explained in the methods section. Calculating the active values proved
important when analyzing active peak and slope due to the inherent passive characteristics of the
tissues involved in muscle contraction and joint stabilization, such as tendons and ligaments.
Calculating active values was less important for EMG peak and area, because EMG activities are
muscle responses to neuronal inputs, and only traces of EMG activities were present during
isoflurane anesthesia (figure 2-1b, right –blue and green trances). The long-term tsDCS study data
show that mice treated with anodal tsDCS had significant reductions in all four parameters
compared to the other groups (figure 3-3). A plausible explanation to this finding involves the
modulating effects of tsDCS on three components that directly affect the stretch reflex amplitude.
These components are gamma motor neuron activity, Ia afferent-motor neuron synapse, and
interneurons activity.
The reduction of active muscle resistance with anodal tsDCS (figure 3-3a) can, at least
partially, be attributed to the current’s ability to modify the activation threshold of muscle spindles.
Matthews in 1972 found that the dynamic and static activation threshold of the muscle spindle
could be controlled by two different types of motor neurons, the dynamic and static gamma
efferents, respectively (Matthews, 1972). In this context, any activity modification of the gamma
motor neuron caused by DC can have a direct impact on the activation threshold of the muscle
spindle. This notion was confirmed when gamma efferents were found to exhibit decreased evoked
activity with anodal current, and increased evoked activity with cathodal current (Ahmed, 2016).
There are two defined mechanisms through which tsDCS can modulate gamma motor
neurons activities: 1- direct modification of their membrane potential, 2- indirect modification of
their presynaptic transmission (Ahmed, 2011; Ahmed, 2013a; Ahmed, 2013b; Ahmed, 2014b;
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Ahmed, 2016; Bolzoni and Jankowska, 2015; Eccles et al., 1962). As explained by Ahmed 2016,
gamma motor neurons have high input resistance due to their small size, which makes their
membrane potentials less responsive to the electrotonic spread of tsDCS, possibly favoring the
indirect presynaptic mechanism pathway.
Direct Current-Induced Calcium Accumulation and Neuronal Plasticity
Calcium is responsible for initiating and modulating a variety of activities within the
cell, such as control of neurotransmitter release (Borst and Sakmann, 1996), long-term changes in
synaptic transmission associated with memory (Dunwiddie and Lynch, 1979; Nicoll et al., 1989;
Turner et al., 1982; Wang and Stelzer, 1996; Yasuda and Tsumoto, 1996), axonal regeneration
(Hannila and Filbin, 2008; Henley et al., 2004), and activation of kinases that mediate gene
expression (Bading, 1999; Li et al., 2016). One intriguing effect of tsDCS on neural tissue is its
ability to redistribute calcium ions. DC current was found to increase calcium accumulations in
axons, synaptosomes and segments of the spinal cord, where anodal current was more effective in
the axons and cathodal current was more effective in synaptosomes (Wieraszko and Ahmed,
2016). Early work investigating the effect of DC current on the monosynaptic stretch reflex
junction shows that anodal current decreased the amounts of neurotransmitter release (Hubbard
and Willis, 1962b), and cathodal current produced the opposite effect (Hubbard and Willis, 1962a).
It is important to note that our tsDCS spinal electrode, located over the injured segment, should
target different types of neurons and neuronal structures. These structures may include local
interneurons and terminals of descending axons from higher spinal segments and the brain.
However, importantly, the anodal current will have a direct effect on the Ia-motor neuron
synapses, whether on those that survived the contusion injury, or the intact ones in the surrounding
area. Therefore, the decrease in stretch responses found with anodal tsDCS (figure 3-3) can be
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explained as a direct result of calcium influx, modulating the spontaneous quantal neurotransmitter
release at the Ia-motor neuron synapses. The increased spontaneous transmitter release possibly
depletes its presynaptic concentrations, causing depressed evoked potentials seen as reduced EMG
activities during anodal tsDCS.
Interestingly, the intracellular increased calcium mobilization may not only explain the
short-term decreased spasticity found during anodal tsDCS, but can also explain the continuation
of spasticity reduction in the long-term study. DC was found to continue modulating intracellular
calcium concentrations for hours after its termination, possibly by increasing the activity of
membrane-bound calcium channels, or activating and relocating calcium channels into the
membrane (Wieraszko and Ahmed, 2016). Additionally, DC was found to exert synaptic
modulations, where anodal current increased, and cathodal current decreased long-term
potentiation (LTP) (Podda et al., 2016; Ranieri et al., 2012). Therefore, the mechanism by which
DC exerts its long-term effect can alternatively be explained in light of synaptic plasticity (MonteSilva et al., 2013).
Gabapentin
Initially emerged as an antiepileptic drug (Johannessen and Ben-Menachem, 2006) and
later used to treat neuropathic pain (Rosner et al., 1996), GABAp has a structure that is closely
related to GABA (Rose and Kam, 2002). The mechanism through which GABAp exerts its action
is not fully understood (Pfizer, 2014; Sills, 2006), and has been a subject of considerable debate for
a number of reasons: despite early notion, GABAp does not bind GABAA (Rose and Kam, 2002)
nor GABAB (Lanneau et al., 2001) receptors, and does not seem to affect the concentration,
synthesis, or synaptic clearance of GABA (Pfizer, 2014). However, a strong body of evidence
indicates that GABAp has an affinity for α2δ-1, (Gee et al., 1996; Marais et al., 2001; Patel and
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Dickenson, 2016), a subunit component of the voltage-gated calcium channel, responsible for its
trafficking (Dolphin, 2012), membrane localization (Dolphin, 2013), and more importantly,
modulation of calcium current density (De Waard and Campbell, 1995). GABAp functions as α2δ1 ligand, causing disruption of calcium channel trafficking (Hendrich et al., 2008) and reduction of
calcium current. α2δ-1 subunits are upregulated in the sensory neurons of the dorsal root ganglion
(DRG) after peripheral nerve injury (Bauer et al., 2009; Lana et al., 2014), and upregulated in the
dorsal, but not the ventral, spinal cord, 30-40 days post-SCI (Boroujerdi et al., 2011). Over
expression of α2δ-1 has been associated with the increased surface expression of calcium channels
(Gurnett et al., 1996), and increased excitability of the dorsal spinal cord (Li et al., 2006; Nguyen
et al., 2009). And in the presence of the astrocyte-secreted protein thrombospondin, in a process
independent of the calcium channel current, α2δ-1 increases excitatory synaptogenesis (Eroglu et
al., 2009). These facts underline the important function of α2δ-1 in modulating calcium current and
neuronal plasticity. Prior work attributes spasticity, in part, to increases in presynaptic
glutamatergic signaling, leading to motor neuron hyper-excitability (Kitzman, 2006). Therefore,
the decreased peak resistance encountered after GABAp injection (figure 3-7a) can be explained as
a reduction in presynaptic calcium current due to GABAp binding its α2δ-1 receptor, leading to
decreased quantal glutamate release. The enhanced reduction of peak resistance induced by anodal
tsDCS after GABAp injection (figure 3-7b) is probably due to depletion of the presynaptic
glutamate reserves as a result of enhanced spontaneous transmitter release (See Chapter 4 on DCinduced calcium accumulation and neuronal plasticity).
Morphine
Systemically administered opiates, such as morphine, cause dose-dependent muscular
rigidity (Havemann et al., 1980; Vučković et al.; Wand et al., 1973); however, the exact mode of
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action is not clear. A number of brain structures have been implicated in opioid-induced rigidity,
such as the basal ganglia (Slater and Starkie, 1987), locus coeruleus (Lui et al., 1989), thalamus
(Ossowska et al., 1986), periaqueductal gray, and nucleus raphe pontis (Weinger et al., 1991). It
has been suggested that morphine interacts with the dopaminergic receptors in the striatum,
reducing the amounts of released dopamine (Kuschinsky and Hornykiewicz, 1972), through a
mechanism similar to that of Parkinson’s disease (PD). Though the reduction in the levels of
dopamine in PD are caused by loss of dopaminergic nigrostriatal neurons, (Korchounov et al.,
2010), morphine rigidity is likely due to inhibition of tyrosine hydroxylase, the enzyme that
catalyzes the rate-limiting step in dopamine synthesis (Freye, 1976). Opioid rigidity was also
explained as a result of the interaction with the opiate binding receptors in the striatum,
particularly the mu (μ) type (Goldblum and Loew, 1991; Vankova et al., 1996) located in the head
of the caudate nucleus (Havemann et al., 1980). Opioid (μ) receptors are not exclusive to the brain.
They are abundant in the spinal cord and DRG where they are implicated in the local nociceptive
depressive effects of opioids, segmentally and peripherally (Besse et al., 1990; Stein, 2003). It
seems that the opioid-induced anti-nociceptive spinal depression is independent of the opioid
effect on the brain, and independent of the influence of the descending connections (Chen and Pan,
2006). However, this may not be the case for opioid-induced rigidity, where supraspinal centers
plays a major role (Kuschinsky et al., 1977; Vankova et al., 1996). Supraspinal involvement had
been confirmed via spinalization experiments that abolished morphine-induced rigidity, where
descending influence excited the extensor alpha motor neurons (Kuschinsky et al., 1977) and
inhibited the flexor alpha motor neurons (Seeber et al., 1978).
The results show palpable morphine-induced extensor muscle rigidity, 35 minutes after
morphine injection (figure 3-8a), and significant peak resistance responses in all three passive
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stretch speeds compared to baseline (figure 3-8b). Although the immediate response to anodal
tsDCS was a reduction in active peak resistance, the resistance was still significant compared to
baseline. However, 10 minutes after anodal tsDCS, the morphine-induced resistance was no longer
significant, and the reduction continued for 20 minutes after the initial application of anodal tsDCS
(figure 3-8b).
The increased peak resistance of the TS (an ankle extensor) following morphine
injection (figure 3-8b) confirms the findings reported by Seeber et al. (1978). And although the
anticipated reduction in the tibialis anterior muscle tone (ankle flexor) could not be assessed due to
stretch apparatus limitations, it is assumed to be present. Since the tibialis anterior muscle is a TS
antagonist, its morphine-induced tone reduction can be viewed as an added force that can enhance
the peak resistance of the TS stretch. So, two forces are contributing to the increased TS stretch
peak resistance: 1- its morphine-induced rigidity, and 2- the force added by the morphine-induced
inhibition of the tibialis anterior muscle. The results show the effectiveness of anodal tsDCS as
modulator of morphine-induced rigidity by overcoming these combined forces. And although the
exact mechanisms of morphine-induced rigidity are not yet fully understood, it seems that anodal
tsDCS reduces morphine-induced extensor muscle rigidity, possibly via decreasing synaptic
activity (See Chapter 4 on DC-induced calcium accumulation and neuronal plasticity).
Locomotion Recovery
Impaired locomotion is one of the most debilitating consequences of SCI. Great body
of research has been dedicated to finding methods to increase the motor function of patients after
SCI. In this study, the long-term effects of tsDCS on spasticity, recovery of gait and skilled
locomotion were assessed. Specific gait parameters that reflect possible tsDCS-induced changes in
spasticity were investigated. The direct relationship between spasticity and locomotion
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abnormalities is well documented in research (Adams and Hicks, 2005; Bravo-Esteban et al., 2013;
Faist et al., 1999; Lamontagne et al., 2001). For example, in healthy humans, continuous
modulation of the stretch reflex is essential for maintaining the proper progression of the gait cycle
(Capaday and Stein, 1986; Crenna and Frigo, 1987). However, after CNS injury, this modulation
suffers different levels of impairment, depending on the extent of spasticity, and the origin of
injury, cerebral or spinal (Faist et al., 1999). Additionally, the level of SCI and the severity of
spasticity have a major impact on the effectiveness of walking, and can predict patterns of gait
abnormalities (Krawetz and Nance, 1996). Moreover, spasticity slows locomotion and interferes
with skilled movements due to co-contraction (Dyer et al., 2011), and associative movements
(Mayer, 2002).
In this study, the data clearly show that repeated anodal tsDCS resulted in Long-term
amelioration of spasticity, as indicated by the significant decreases in active peak resistance, active
resistance slope, and EMG activities (figure 3-3c). However, it was important to investigate
whether the anodal-induced reduction in spasticity can be linked to improved functionality. As
discussed earlier, after SCI, spasticity interferes with the components of the gait cycle; therefore,
significant reductions in spasticity should have normalizing effects on at least some of these
components. This investigation concentrated on parts of the cycle that involve stretches of the TS
during various parts within the stance phase – when the foot is in contact with the ground. In
stance, it is ideal to assess the effects of spasticity on gait, as the TS stretch at different velocities,
which is on par with the definition of spasticity coined by Lance (Lance, 1980).
To assess the effects of tsDCS on gait (figure 3-4), three locomotion-related parameters
were investigated: rising slope, peak paw area, and falling slope. These parameters were chosen
due to their sensitivity to changes in the stance phase of the gait cycle. For example, the beginning
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of the rising slope marks the initiation of the stance phase, when the animal’s heel strikes the
ground. The rest of the rising slope corresponds to the progressive lowering of the foot to the
ground, as the animal shifts body weight (the loading response) to that foot. The shifting continues
till midstance – a point at the middle of the stance phase with the foot flat on the ground. At
midstance, the second parameter, the peak paw area, was measured. The falling slope, however,
follows the end of midstance, and begins as heel starts of elevate (heel off), and continues as the
foot gradually prepares for push off to propel the animal forward.
It is important to note that spastic animals show tip-toeing paw placement during the
heel strike and will have a decreased peak paw area. They will also have a lower rising and falling
slops due to the increased transition time caused by spasticity. Consequently, changes in the peak
paw area, rising slope, or falling slope can be directly attributed to modulation of the severity of
spasticity. In order to appreciate this relationship, one must remember that the slopes provide
important temporal information regarding the lengthening and contractibility of the TS during
different points of stance. For example, an increased falling slope after anodal tsDCS signifies a
faster transition from midstance to push-off. During most of the stance phase, the TS undergo
progressive lengthening, as the ankle flexes, and the body moves forward. In spastic animals, this
lengthening triggers locomotion-interfering reflexive contractions due to the impaired reflex
modulation associated with spasticity (Faist et al., 1999). Therefore, the significant increases in the
falling and rising slopes following anodal treatment shown by the data (figure 3-4d, middle and
lower graphs), indicate enhanced transition, and decreased transition time. Additionally, the peak
paw area for the same animals also increased during midstance for both slow and fast speeds
(figure 3-4d, top), compared to sham-treated animals (figure 3-4c top).
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These data collaborate with our observations during locomotion testing, as the anodaltreated animals gradually changed their tip-toeing paw placements during midstance to foot-flat
placements. Considering that the anodal-treated animals didn’t receive any additional locomotion
training compared to the animals of the other groups, these findings show genuine intrinsic plastic
changes. Therefore, it is safe to deduce that increased paw area signifies improved modulation of
the stretch reflex of the foot and toe flexors in response to passive stretches from the ground. And
that the increased rising and falling slopes signify improved modulation of the stretch reflex in
response to stretches of the TS during the stance phase.
Our data show consistency with respect to the effect of anodal tsDCS as a stretch reflex
circuit modulator. As explained earlier, long-term anodal tsDCS restored RDD (figure 3-6e and f).
It also reduced stretch reflex-induced peak resistance, resistance slope and EMG activity, acutely
and chronically, at all different tested speeds, after SCI (figure 3-3). These findings point to a
modulated stretch reflex circuit model that is capable of receiving and executing input signals from
multiple CNS sources. For example, the new modulatory properties of the stretch reflex circuit are
not only capable of adjusting to inputs received from the locomotion-mediating central pattern
generators, but are also capable of adjusting to the skilled-movement commands from higher CNS
centers. This was confirmed by the improvement in skilled locomotion scores exhibited by the
anode-treated animals (figure 3-5b and c).
Study Weaknesses
The animals of the immediate effect study were evaluated for only one hour after treatment,
with no subsequent assessments. Follow up evaluations should have been conducted to find a
threshold in the treatment protocol (the least number of treatment session) where the immediate
effect becomes long-term.
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Future Studies
1- Follow up investigations would allow us to quantify the amount of time it takes for
the electrophysiological effect of tsDCS to dissipate, and assess the amount of time needed for the
initiation and completion of protein synthesis necessary for the long-term effect changes. More
evaluations at different set points during the treatment protocol can reveal the long-term effect
threshold.
2- Assuming that LTP-, LTD-like mechanisms are behind the long-term changes
encountered post-tsDCS, a subsequent study will be needed to assess protein changes and map
their pathway(s). The application of a protein synthesis inhibitor, anisomycin, within three hours of
stimulation may also allow us to investigate treatment threshold.
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